
IOVA
USDIovance Biotherapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.250
Kõrge
$2.380
Madal
$2.080
Maht
17.39M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
913.0M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
13.73M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif., Nov. 03, 2025
HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $9
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics with a Buy and lowers the price target from $20 to $9.
Seotud aktsiad
BTBDW
BT Brands Inc. Warrant
NTRSO
Northern Trust Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock
APRE
Aprea Therapeutics Inc.
GPOR
Gulfport Energy Corporation Common Shares
CLBK
Columbia Financial Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.